| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Transcription factor p65 |
|---|
| Ligand | BDBM50440270 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Inhibition Assay |
|---|
| IC50 | 600±n/a nM |
|---|
| Citation |  Vander Jagt, DL; Deck, LM Substituted cis- and trans-stilbenes as therapeutic agents US Patent US8980954 Publication Date 3/17/2015 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Transcription factor p65 |
|---|
| Name: | Transcription factor p65 |
|---|
| Synonyms: | NFKB3 | Nuclear factor NF-kappa-B | Nuclear factor NF-kappa-B p65 subunit | RELA | TF65_HUMAN | v-rel reticuloendotheliosis viral oncogene homolog A isoform 1 |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 60211.92 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Q04206 |
|---|
| Residue: | 551 |
|---|
| Sequence: | MDELFPLIFPAEPAQASGPYVEIIEQPKQRGMRFRYKCEGRSAGSIPGERSTDTTKTHPT
IKINGYTGPGTVRISLVTKDPPHRPHPHELVGKDCRDGFYEAELCPDRCIHSFQNLGIQC
VKKRDLEQAISQRIQTNNNPFQVPIEEQRGDYDLNAVRLCFQVTVRDPSGRPLRLPPVLS
HPIFDNRAPNTAELKICRVNRNSGSCLGGDEIFLLCDKVQKEDIEVYFTGPGWEARGSFS
QADVHRQVAIVFRTPPYADPSLQAPVRVSMQLRRPSDRELSEPMEFQYLPDTDDRHRIEE
KRKRTYETFKSIMKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINY
DEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQA
VAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQ
GIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADM
DFSALLSQISS
|
|
|
|---|
| BDBM50440270 |
|---|
| n/a |
|---|
| Name | BDBM50440270 |
|---|
| Synonyms: | CHEMBL215432 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C15H14O3 |
|---|
| Mol. Mass. | 242.2699 |
|---|
| SMILES | COc1ccc(\C=C\c2ccc(O)c(O)c2)cc1 |
|---|
| Structure | 
|
|---|
Search and Browse
